These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8359032)

  • 1. Keratoconus corneas: increased gelatinolytic activity appears after modification of inhibitors.
    Brown D; Chwa MM; Opbroek A; Kenney MC
    Curr Eye Res; 1993 Jun; 12(6):571-81. PubMed ID: 8359032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased gelatinolytic activity in keratoconus keratocyte cultures. A correlation to an altered matrix metalloproteinase-2/tissue inhibitor of metalloproteinase ratio.
    Kenney MC; Chwa M; Opbroek AJ; Brown DJ
    Cornea; 1994 Mar; 13(2):114-24. PubMed ID: 8156782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collagenolytic/gelatinolytic metalloproteinases in normal and keratoconus corneas.
    Fini ME; Yue BY; Sugar J
    Curr Eye Res; 1992 Sep; 11(9):849-62. PubMed ID: 1424728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of TIMP-1, TIMP-2, TIMP-3, gelatinase A and gelatinase B in pathological human corneas.
    Kenney MC; Chwa M; Alba A; Saghizadeh M; Huang ZS; Brown DJ
    Curr Eye Res; 1998 Mar; 17(3):238-46. PubMed ID: 9543631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a human corneal metalloproteinase inhibitor (TIMP-1).
    Opbroek A; Kenney MC; Brown D
    Curr Eye Res; 1993 Oct; 12(10):877-83. PubMed ID: 7507419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Keratoconus: matrix metalloproteinase-2 activation and TIMP modulation.
    Smith VA; Matthews FJ; Majid MA; Cook SD
    Biochim Biophys Acta; 2006 Apr; 1762(4):431-9. PubMed ID: 16516444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased levels of catalase and cathepsin V/L2 but decreased TIMP-1 in keratoconus corneas: evidence that oxidative stress plays a role in this disorder.
    Kenney MC; Chwa M; Atilano SR; Tran A; Carballo M; Saghizadeh M; Vasiliou V; Adachi W; Brown DJ
    Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):823-32. PubMed ID: 15728537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of membrane-type 1 matrix metalloproteinase (MT1-MMP) and MMP-2 in normal and keratoconus corneas.
    Collier SA; Madigan MC; Penfold PL
    Curr Eye Res; 2000 Aug; 21(2):662-8. PubMed ID: 11148603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The control of matrix metalloproteinase-2 expression in normal and keratoconic corneal keratocyte cultures.
    Parkin BT; Smith VA; Easty DL
    Eur J Ophthalmol; 2000; 10(4):276-85. PubMed ID: 11192834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Over-expression of a gelatinase A activity in keratoconus.
    Smith VA; Hoh HB; Littleton M; Easty DL
    Eye (Lond); 1995; 9 ( Pt 4)():429-33. PubMed ID: 7498560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases and TIMPS in cultured C57BL/6J-cpk kidney tubules.
    Rankin CA; Suzuki K; Itoh Y; Ziemer DM; Grantham JJ; Calvet JP; Nagase H
    Kidney Int; 1996 Sep; 50(3):835-44. PubMed ID: 8872958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate.
    Itoh Y; Binner S; Nagase H
    Biochem J; 1995 Jun; 308 ( Pt 2)(Pt 2):645-51. PubMed ID: 7772054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of gelatinases A and B, and TIMPs 1 and 2 during corneal wound healing.
    Ye HQ; Azar DT
    Invest Ophthalmol Vis Sci; 1998 May; 39(6):913-21. PubMed ID: 9579471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mosaic structure of the secreted ECM metalloproteases and interaction of the type IV collagenases with inhibitors.
    Goldberg GI; Collier IE; Eisen AZ; Grant GA; Marmer BL; Wilhelm SM
    Matrix Suppl; 1992; 1():25-30. PubMed ID: 1336109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered gelatinolytic activities in an apparent unilateral keratoconus patient. A case report.
    Brown DJ; Chwa M; Opbroek AJ; Kenney MC
    Cornea; 1994 Mar; 13(2):108-13. PubMed ID: 8156781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative studies of a 92-kDa gelatinolytic metalloproteinase from U937 cells and matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts.
    Morodomi T; Suzuki K; Sasaguri Y; Morimatsu M; Nagase H
    Matrix Suppl; 1992; 1():87-8. PubMed ID: 1480100
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.
    Mackay AR; Ballin M; Pelina MD; Farina AR; Nason AM; Hartzler JL; Thorgeirsson UP
    Invasion Metastasis; 1992; 12(3-4):168-84. PubMed ID: 1284126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of degradative enzymes and protease inhibitors in corneas with keratoconus.
    Zhou L; Sawaguchi S; Twining SS; Sugar J; Feder RS; Yue BY
    Invest Ophthalmol Vis Sci; 1998 Jun; 39(7):1117-24. PubMed ID: 9620070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase 2: involvement in keratoconus.
    Smith VA; Easty DL
    Eur J Ophthalmol; 2000; 10(3):215-26. PubMed ID: 11071029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the corneal degradation in keratoconus caused by matrix-metalloproteinases?
    Collier SA
    Clin Exp Ophthalmol; 2001 Dec; 29(6):340-4. PubMed ID: 11778801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.